SynCore Biotechnology Co (4192.TWO) Stock Price

SynCore Biotechnology Co Price

CLOSED
16.55
​
Market closed

Over the last 12 years SynCore Biotechnology Co grew revenue by 34.6% annually, reaching 27.04 M TWD. For SynCore Biotechnology Co, the net margin of -169.2% is up versus -6,609.0% a few years ago.

SynCore Biotechnology Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SynCore Biotechnology Co business model & stock analysis

SynCore Biotechnology Co Ltd, based in Dongshan, Yilan, Taiwan, operates in the Health Care sector with a focus on Pharmaceuticals. The company develops new drugs and integrates technology, employing 50 full-time staff. Its main product is SB03 Veregen, alongside research and development of anticancer drugs SB01 (injection and oral forms). SynCore primarily distributes its products within Taiwan.

Frequently asked questions about SynCore Biotechnology Co

Converted at the current exchange rate, the SynCore Biotechnology Co share trades at 0.45 EUR (16.55 TWD).

The revenue cannot currently be calculated for SynCore Biotechnology Co.

The profit cannot currently be calculated for SynCore Biotechnology Co.

The P/E ratio cannot be calculated for SynCore Biotechnology Co at the moment.

The P/S cannot be calculated for SynCore Biotechnology Co currently.

The Eulerpool Quality Score for SynCore Biotechnology Co is 4/10.

The ISIN of SynCore Biotechnology Co is TW0004192000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of SynCore Biotechnology Co is 4192.TWO. The ticker symbol is used to trade SynCore Biotechnology Co shares on the stock exchange.

Fair ValueTerminal
15.39 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
540,860.00 TWD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Aug 29, 2013
ISIN
TW0004192000
Cusip
Y8T27T100
Market capitalization
581.90 M TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
2.37
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-18.63 %
Last updated Nov 11, 2026, 3:54 AM

SynCore Biotechnology Co Peer Group

SynCore Biotechnology Co FIGI

4192:TT (Taipei Stock Exchange) · BBG00553G5T6